The 15th annual Mycroft Signs Speedway in Lights 5K presented by Fleet Feet returns to Bristol Motor Speedway on Sunday, Nov. 16, when more than 1,000 festive participants will be the first to tour ...

Multitel has introduced a gravity lowering system on its 71m MJE 710 in collaboration with Flodraulic Motion Systems ...

As the race to develop oncology bispecifics heats up, Pfizer has offered a first look at its strategy to dethrone Keytruda and establish its ...

"Sort of," the PFY nods. "A survey of a couple of inboxes reveals a 'top secret, not to be mentioned to anyone' discussion at ...

Pfizer could soon launch a multi-billion dollar bid for immunotherapy rivals Bristol-Myers Squibb. But moves into new fields of innovation and digital tech – such as Roche’s buyout of Flatiron - are ...

Interest in ivermectin for kidney cancer has come primarily from preclinical studies. Authors of a review from China stated ...

If homes are to be built and we are to transition to clean, secure energy, the construction sector will need to adopt new technologies.

BMS Stangeland will utilise it's ten new rough terrain cranes and five new all terrains from Sany across the Nordic region.

Q3 2025 Earnings Call November 13, 2025 3:00 AM ESTCompany ParticipantsWolfgang Kirsch - Co-Chief Executive Officer ...

Prime Medicine, Inc. ( PRME) Discusses Liver Disease Franchise Strategy With Focus on Wilson Disease November 12, 2025 8:00 AM EST ...

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory ...